About Solventum Corporation
https://www.solventum.comSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
CEO
Bryan C. Hanson
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 3 of 509
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
BTIG
Buy
Argus Research
Buy
Piper Sandler
Overweight
Morgan Stanley
Overweight
Wells Fargo
Equal Weight
UBS
Neutral
Grade Summary
Showing Top 6 of 9
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:17.12M
Value:$1.37B
INDEPENDENT FRANCHISE PARTNERS LLP
Shares:12.9M
Value:$1.03B
BLACKROCK INC.
Shares:11.04M
Value:$883.67M
Summary
Showing Top 3 of 925
About Solventum Corporation
https://www.solventum.comSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.1B ▼ | $1.04B ▲ | $1.27B ▲ | 60.4% ▲ | $7.26 ▲ | $1.72B ▲ |
| Q2-2025 | $2.16B ▲ | $961M ▼ | $90M ▼ | 4.16% ▼ | $0.52 ▼ | $328M ▲ |
| Q1-2025 | $2.07B ▼ | $962M ▼ | $137M ▲ | 6.62% ▲ | $0.79 ▲ | $271M ▲ |
| Q4-2024 | $2.08B ▼ | $983M ▲ | $31M ▼ | 1.49% ▼ | $0.18 ▼ | $270M ▼ |
| Q3-2024 | $2.08B | $890M | $122M | 5.86% | $0.7 | $407M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.64B ▲ | $13.97B ▼ | $8.99B ▼ | $4.99B ▲ |
| Q2-2025 | $492M ▼ | $15.07B ▲ | $11.43B ▲ | $3.65B ▲ |
| Q1-2025 | $534M ▼ | $14.53B ▲ | $11.27B ▼ | $3.26B ▲ |
| Q4-2024 | $762M ▼ | $14.46B ▼ | $11.5B ▼ | $2.96B ▼ |
| Q3-2024 | $772M | $14.74B | $11.55B | $3.19B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.27B ▲ | $76M ▼ | $3.77B ▲ | $-2.69B ▼ | $1.15B ▲ | $-21M ▼ |
| Q2-2025 | $90M ▼ | $169M ▲ | $-110M ▲ | $-110M ▲ | $-42M ▲ | $59M ▲ |
| Q1-2025 | $137M ▲ | $29M ▼ | $-114M ▲ | $-139M ▼ | $-228M ▼ | $-80M ▼ |
| Q4-2024 | $31M ▼ | $219M ▲ | $-127M ▼ | $-104M ▲ | $-10M ▲ | $92M ▲ |
| Q3-2024 | $122M | $169M | $-93M | $-202M | $-125M | $76M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product | $3.13Bn ▲ | $1.60Bn ▼ | $1.67Bn ▲ | $1.59Bn ▼ |
CEO
Bryan C. Hanson
Compensation Summary
(Year )
ETFs Holding This Stock
Summary
Showing Top 3 of 509
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
BTIG
Buy
Argus Research
Buy
Piper Sandler
Overweight
Morgan Stanley
Overweight
Wells Fargo
Equal Weight
UBS
Neutral
Grade Summary
Showing Top 6 of 9
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:17.12M
Value:$1.37B
INDEPENDENT FRANCHISE PARTNERS LLP
Shares:12.9M
Value:$1.03B
BLACKROCK INC.
Shares:11.04M
Value:$883.67M
Summary
Showing Top 3 of 925